Quantcast
Last updated on April 24, 2014 at 11:22 EDT

Concord Medical Reports First Quarter 2013 Financial Results

May 21, 2013

BEIJING, May 21, 2013 /PRNewswire/ — Concord Medical Services Holdings Limited (“Concord Medical” or the “Company”) (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang’an Hospital, today reported its unaudited consolidated financial results for the first quarter ended March 31, 2013([1]).

First Quarter 2013 Highlights

  • Total net revenue, which consists of net revenues generated from the network business and hospital business, was RMB203.9 million ($32.8 million) in the first quarter of 2013, a 91.1% increase from RMB106.7 million in the first quarter of 2012.
  • Gross profit in the first quarter of 2013 was RMB71.5 million ($11.5 million), a 14.8% increase from RMB62.3 million in the first quarter of 2012.
  • Net income attributable to ordinary shareholders in the first quarter of 2013 was RMB19.7 million ($3.2 million), an 18.6% decrease from RMB24.2 million in the first quarter of 2012.
  • Basic and diluted earnings per American depositary share (“ADS”)([2]) in the first quarter of 2013 were RMB0.44 ($0.07).
  • Adjusted EBITDA([3]) (non-GAAP) in the first quarter of 2013 was RMB89.0 million ($14.3 million), a 21.0% increase from RMB73.6 million in the first quarter of 2012.

Dr. Jianyu Yang, Chairman and Chief Executive Officer of Concord Medical, stated, “I am pleased with the financial results of first quarter of 2013, especially the strong revenue growth, healthy gross profit and Adjusted EBITDA compared with the first quarter of 2012. During the quarter, we benefited from the continuously increasing demand from the general population for high-quality and affordable healthcare services. We saw a positive momentum in patient number growth in both our network and hospital businesses.”

“Since 2012, we have increased our investment in the telemedicine and web business units. In telemedicine, we are building a network based on data transmission and storage technology that will enable doctors and physicists in our network to more easily communicate and consult with each other on cases. We are also setting up telemedicine centers in hospitals in remote areas so that the doctors there can benefit from the knowledge and expertise of other doctors in the CCM network. We have also invested in web-based and mobile marketing business units that will helped our centers targeting new patients more effectively. We believe that these new business units will bring incremental future revenues to the company. We plan to continue investing in these business units.”

“Based on our estimates of the business environment and progress so far in 2013, we are confident that we will achieve the 2013 revenue targets of RMB930 million to RMB975 million issued in the first quarter.”

“On May 15, 2013, we announced the signing of a $50 million loan package with International Finance Corporation (“IFC”). We will use the loan to expand our network of radiotherapy centers in China as well as to build the planned specialty hospitals in Beijing and Guangzhou. These hospitals represent crucial components of our growth strategy to create a nationwide network of oncology centers and specialty hospitals, providing high-quality radiotherapy services to all of our patients in China.”

“We plan to start construction of our specialty cancer hospital in Guangzhou during the second half of 2013. Also, we have made progress towards obtaining the necessary administrative approvals related to the Beijing hospital project, in cooperation with Sino-Japanese Friendship Hospital. Once both hospitals are open, they will provide high-end radiotherapy services, based on international standard of quality assurance and planning.”

Recent Developments

IFC loan Agreement – On May 15, 2013, the Company announced that it had signed a US$50 million loan package agreement with IFC, a member of the World Bank Group focusing on private sector development in emerging markets.

Share repurchase programOn October 9, 2012, the Company announced that its board of directors has approved the extension of its share repurchase program originally approved by the board of directors on September 30, 2011. During the first quarter of 2013, the Company repurchased 105,067 ADSs, representing 315,201 ordinary shares for a total $0.4 million, including commissions.

Through March 31, 2013, the Company has repurchased 2,293,808 ADSs, representing 6,881,424 ordinary shares, in the open market, for a total consideration of $8,068,225 (including commissions) under the share repurchase program. As of March 31, 2013, the Company had 18.9 million ADSs outstanding, representing 56.7 million ordinary shares.

First quarter 2013 results by segment

Network business

The Company added one radiotherapy center in the first quarter of 2013, bringing the total number of centers in operation to 137 in 54 cities in China as of March 31, 2013. As of the same date, the Company had entered into agreements to establish 11 additional centers.

Net revenues from the network business were RMB111.7 million ($18.0 million)( )for the first quarter of 2013, representing an increase of 4.6% from the first quarter of 2012, primarily due to increase in number of patients in our existing centers as well as contribution from the new centers opened during 2012.

Gross profit margin of the network business was 55.4% for the first quarter of 2013, as compared with 58.4% for the first quarter of 2012. The lower gross profit margin was primarily due to increased compensation and operating cost at our centers.

Capital expenditure of the network business was RMB33.8 million ($5.4 million) for the first quarter of 2013, compared with RMB36.0 million in the first quarter of 2012.

Selling expenses in the network business were RMB16.5 million ($2.7 million) for the first quarter of 2013, representing an increase of 106% from the first quarter of 2012. The increase was mainly due to selling expenses relating to our telemedicine and web business of RMB4.5 million ($0.7 million). The Company also incurred higher marketing and promotion expenses relating to newly opened centers.

General and administrative expenses in the network business were RMB20.8 million ($3.4 million), representing an increase of 22.9% from the first quarter of 2012. The increase was mainly due to general and administrative expenses relating to the telemedicine and web business of RMB2.1 million ($0.3 million).

Accounts receivable from the network business was RMB185.9 million ($29.9 million) as of March 31, 2013, as compared to RMB168.3 million as of December 31, 2012. The average period of sales outstanding for accounts receivable, or Days Sales Outstanding (DSO) was 155 days for the first quarter of 2013, as compared to 153 days for the fourth quarter of 2012.

As of March 31, 2013, the Company, not including Chang’an Hospital, had bank credit lines of RMB2,217 million ($357.1 million), of which RMB912.0 million ($146.8 million) was utilized.

During the first quarter of 2013, the Company handled 7,517 patient treatment cases and 71,084 patient diagnostic cases in the center network, representing a 4.4% decrease and 59.6% increase from the first quarter of 2012, respectively.

Hospital business

Financial results of Chang’an Hospital were consolidated into our results of operations since the third quarter of 2012 after we consummated the acquisition of 52% equity interest in Chang’an Hospital. Net revenues from the hospital business were RMB92.3 million ($14.9 million)( )for the first quarter of 2013, which consisted of:

  • outpatient revenues of RMB18.4 million ($3.0 million), representing 20% of the net revenues from the hospital business;
  • inpatient revenues of RMB34.1 million ($5.5 million), representing 37% of the net revenues from the hospital business; and
  • medicine revenues of RMB39.8 million ($6.4 million), representing 43% of the net revenues from the hospital business.

Cost of service for the hospital business for the first quarter of 2013 was RMB82.6 million ($13.3 million), of which the medicine cost was RMB33.9 million ($5.5 million) and the medical service cost was RMB48.7 million ($7.8 million).

Gross profit margin of the hospital business was 10.5% for the first quarter of 2013.

Capital expenditure of the hospital business was RMB9.8 million ($1.6 million) for the first quarter of 2013.

General and administrative expenses in the hospital business were RMB4.6 million ($0.7 million).

As of March 31, 2013, Chang’an Hospital had accounts receivable of RMB30.8 million ($5.0 million), representing days sales outstanding of 36 days, as compared to 34 days for the fourth quarter of 2012. The accounts receivable was mainly from medical revenues covered by various government-sponsored insurance programs. Chang’an Hospital settles the balance with the local social insurance bureau on a periodic basis.

Chang’an Hospital received 117,773 outpatients and 7,530 inpatients for the first quarter of 2013. The average bed utilization for the quarter was 89.2%. The average days of hospital stay was 10.0 days per patient for the quarter. Chang’an Hospital operated 1,015 beds as of March 31, 2013.

Chang’an Hospital is a leading private-owned, general service, for-profit hospital, located in Xi’an, Shanxi Province. Established in 2002, Chang’an Hospital had 57 departments with over 1,250 medical and non-medical staff as of March 31, 2013.

2013 Outlook

Based on current market and operating conditions, estimated business expansion and forecasted Chang’an Hospital financial results, Concord Medical expects to generate total net revenues in an estimated range of RMB930 million to RMB975 million in 2013, which would represent a 40% to 47% increase from 2012. The revenues from network business and hospital business as percentages to total revenues are expected to be approximately 55% and 45% in 2013, respectively. Finally, the Company is targeting to start construction of the specialty cancer oncology hospital in Guangzhou in 2013.

These estimates are based on current market and operating conditions, are subject to change, and may be impacted positively or negatively by factors outside the Company’s control, including but not limited to macroeconomic events in the markets in which the Company operates. See “Safe Harbor Statement” below for additional information regarding forward-looking statements.

Conference Call Information

Concord Medical’s management will hold an earnings conference call at 8:00 a.m. Eastern Daylight Time on May 22, 2013 (8:00 p.m. Beijing/Hong Kong time on May 22, 2013).

Dial-in details for the earnings conference call are as follows:

    U.S. Toll Free:                   1-866-519-4004

    U.K. Toll Free:                                          08082346646

    International:                                           65 67239381

    China Toll Free:                  400-620-8038 / 800-819-0121

    Hong Kong Toll Free:              800-930-346

    Passcode:                         CCM

A replay of the conference call may be accessed by phone at the following numbers for 7 days:

    U.S. Toll Free:                   1-855-452-5696

    International:                               +61 2 8199 0299

    Conference ID:                                      71197242

Additionally, a live and archived webcast of this conference call will be available at http://ir.concordmedical.com/.

About Concord Medical

Concord Medical Services Holdings Limited operates the largest network of radiotherapy and diagnostic imaging centers in China, measured by revenues and the number of centers in operation and is the parent of Chang’an Hospital. As of March 31, 2013, the Company operated a network of 137 centers with 77 hospital partners that spanned 54 cities and 24 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

Safe Harbor Statement

This news release may contain “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “should” and “will” and similar expressions. These forward looking statements are based upon management’s current views and expectations with respect to future events and are not a guarantee of future performance. Furthermore, these statements are by their nature, subject to a number of risks and uncertainties that could cause actual performance and results to differ materially from those discussed in the forward-looking statements as a result of a number of factors. Such factors include: the number of new radiotherapy and diagnostic imaging centers opened; the increase in the number of patients in existing centers; the establishment of specialty cancer hospitals; changes in the healthcare industry in China, including changes in the healthcare policies and regulations of the PRC government; technological or therapeutic changes affecting the field of cancer treatment and diagnostic imaging; and possible effects on consumers and hospitals, hospital construction, and suppliers, as a result of inflation and the Chinese government’s policies and actions to control inflation. Further information regarding these and other risks is included in the Company’s filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. The Company does not assume any obligation to update any forward-looking statement, except as required by law.

About Non-GAAP Financial Measures

To supplement the consolidated financial statements presented in accordance with United States Generally Accepted Accounting Principles (“GAAP”), Concord Medical uses certain non-GAAP measures. The Company presents certain of its financial information that is adjusted from results based on GAAP to exclude the impact of share-based compensation expense. The Company believes excluding share-based compensation expense from its GAAP financial measures is useful for its management and investors to assess and analyze the Company’s core operating results, as such expense is not directly attributable to the underlying performance of the Company’s business operations and do not impact its current cash earnings. Concord Medical also believes these non-GAAP measures excluding share-based compensation expense are important in helping investors to understand the Company’s current financial performance and future prospects and to compare business trends among different reporting periods on a consistent basis. In addition, Concord Medical also presents the non-GAAP measure of Adjusted EBITDA, which is defined in this announcement as net income plus interest, taxes, depreciation and amortization, share-based compensation expenses, and other adjustments. Other adjustments include foreign exchange losses and other expense income. Furthermore, Adjusted EBITDA eliminates the impact of items that the Company does not consider to be indicative of the performance of the network business and hospital business. The Company believes investors will similarly use Adjusted EBITDA as one of the key metrics to evaluate its financial performance and to compare its current operating results with corresponding historical periods and with other companies in the healthcare services industry. The presentation of these additional measures should not be considered a substitute for or superior to GAAP results or as being comparable to results reported or forecasted by other companies. The non-GAAP measures have been reconciled to GAAP measures in the attached financial information.

For more information, please contact:

Concord Medical Services

Mr. Adam J. Sun (Chinese and English)
+86 10 5957 5266
adam.sun@concordmedical.com

Mr. Ting Jia (Chinese and English)
+86 10 5903 6688 (ext. 809)
ting.jia@concordmedical.com

Ms. Gloria Huang (Chinese and English)
+86 10 5903 6688 (ext. 639)
gloria.huang@concordmedical.com

Solebury Communications

In China:
Ms. Vickie Zhao
CCM@soleburyir.com
(+86) 10 6563-0288 (ext. 801)

In the United States:
Mr. Richard Zubek
rzubek@soleburyir.com
(+1) 203-428-3231

                                                                                                                                        Concord Medical Services Holdings Co., Ltd.

                                                                                                                                                Consolidated Balance Sheets

                                                                                                                                                       (in thousands)

                                                                                                                                                                                    December 31, 2012 (*)            March 31, 2013

                                                                                                                                                                                             RMB                           RMB                   US$

                                                                                                                                                                                                                       (Unaudited)           (Unaudited)

    ASSETS

    Current assets

    Cash                                                                                                                                                                                                     75,382                 181,511               29,225

    Restricted cash, current portion                                                                                                                                                                        284,047                 284,002               45,727

    Accounts receivable                                                                                                                                                                                     210,307                 216,690               34,889

    Inventories                                                                                                                                                                                               8,681                  12,079                1,945

    Prepayments and other current assets                                                                                                                                                                     67,472                 115,309               18,566

    Net investments in direct financing leases, current portion                                                                                                                                              89,451                 114,246               18,395

    Deferred tax assets, current portion                                                                                                                                                                     16,593                  19,617                3,159

    Loan to a noncontrolling shareholder of a subsidiary                                                                                                                                                    100,000                  93,410               15,040

    Amount due from related parties                                                                                                                                                                           1,200                   1,446                  233

    Total current assets                                                                                                                                                                                    853,133               1,038,310              167,179
                                                                                                                                                                                                            -------               ---------              -------

    Non-current assets

    Property, plant and equipment, net                                                                                                                                                                    1,522,920               1,530,599              246,442

    Goodwill                                                                                                                                                                                                292,885                 292,885               47,157

    Intangible asset, net                                                                                                                                                                                   146,512                 138,570               22,311

    Deposits for non-current assets                                                                                                                                                                         162,938                  90,496               14,571

    Net investments in direct financing leases, non-current portion                                                                                                                                         171,545                 222,757               35,866

    Deferred tax assets, non-current portion                                                                                                                                                                 18,110                  16,811                2,707

    Equity method investments                                                                                                                                                                               230,589                 233,100               37,531

    Other non-current assets                                                                                                                                                                                114,758                 114,330               18,408

    Prepaid land lease payments                                                                                                                                                                              90,124                  89,491               14,409

    Indemnification assets                                                                                                                                                                                   61,706                  61,706                9,935

    Total non-current assets                                                                                                                                                                              2,812,087               2,790,745              449,337
                                                                                                                                                                                                          ---------               ---------              -------

    Total assets                                                                                                                                                                                          3,665,220               3,829,055              616,516
                                                                                                                                                                                                          =========               =========              =======

    LIABILITIES AND EQUITY

    Current liabilities

    Short-term bank borrowings                                                                                                                                                                              383,083                 383,140               61,689

    Long-term bank borrowings, current portion                                                                                                                                                              191,473                 245,951               39,601

    Accounts payable                                                                                                                                                                                        100,563                 116,443               18,748

    Accrual for purchase of property, plant and equipment                                                                                                                                                    40,691                  31,165                5,018

    Obligations under capital leases, current portion                                                                                                                                                         2,117                   1,225                  197

    Accrued expenses and other liabilities                                                                                                                                                                   92,040                  98,069               15,790

    Income tax payable                                                                                                                                                                                       22,433                  19,768                3,183

    Deferred revenue, current portion                                                                                                                                                                        18,975                  19,369                3,119

    Amount due to related parties, current portion                                                                                                                                                            5,910                   8,311                1,338

    Deferred tax liabilities, current portion                                                                                                                                                                 2,248                   3,384                  545
                                                                                                                                                                                                              -----                   -----                  ---

    Total current liabilities                                                                                                                                                                               859,533                 926,825              149,228
                                                                                                                                                                                                            -------                 -------              -------

    Non-current liabilities

    Long-term bank borrowings, non-current portion                                                                                                                                                          300,901                 382,926               61,655

    Accrued unrecognized tax benefits & surcharge, non-current portion                                                                                                                                       67,719                  67,719               10,903

    Other long term liabilities                                                                                                                                                                              34,646                  33,336                5,367

    Amount due to related parties, non current                                                                                                                                                               26,828                  26,828                4,320

    Deferred tax liabilities, non-current portion                                                                                                                                                            35,683                  32,855                5,290
                                                                                                                                                                                                             ------                  ------                -----

    Total non-current liabilities                                                                                                                                                                           465,777                 543,664               87,535
                                                                                                                                                                                                            -------                 -------               ------

    Total liabilities                                                                                                                                                                                     1,325,310               1,470,489              236,763
                                                                                                                                                                                                          ---------               ---------              -------

    Commitments and contingencies

    EQUITY

    Ordinary shares                                                                                                                                                                                             105                     105                   17

    Treasury stock                                                                                                                                                                                               (5)                     (4)                  (1)

    Additional paid-in capital                                                                                                                                                                            2,517,496               2,516,986              405,260

    Accumulated other comprehensive loss                                                                                                                                                                    (16,955)                (16,830)              (2,710)

    Accumulated deficit                                                                                                                                                                                    (469,055)               (449,372)             (72,353)
                                                                                                                                                                                                           --------                --------              -------

    Total Concord Medical Services Holdings Limited shareholders' equity                                                                                                                                  2,031,586               2,050,885              330,213

    Noncontrolling interests                                                                                                                                                                                308,324                 307,681               49,540
                                                                                                                                                                                                            -------                 -------               ------

    Total equity                                                                                                                                                                                          2,339,910               2,358,566              379,753
                                                                                                                                                                                                          ---------               ---------              -------

    Total liabilities and equity                                                                                                                                                                          3,665,220               3,829,055              616,516
                                                                                                                                                                                                          =========               =========              =======

    (*) Amounts for the year ended December 31, 2012 were derived from the December 31, 2012 audited consolidated financial statements.

                                                                                                                          Concord Medical Services Holdings Limited

                                                                                                                               Consolidated Statements of Income

                                                                                                                             (in thousands, except per  ADS data)

                                                                                                                                                                    For The Three Months Ended

                                                                                                                                                                        March 31, 2012 (*)               March 31, 2013

                                                                                                                                                                               RMB                             RMB                   US$

    Revenues, net of business tax, value-added tax and related surcharges                                                                                                  (Unaudited)                     (Unaudited)           (Unaudited)

    Network                                                                                                                                                                                     106,731                 111,655                17,978

    Hospital-Medicine income                                                                                                                                                                          -                  39,760                 6,402

    Hospital-Medical service income                                                                                                                                                                   -                  52,499                 8,453
                                                                                                                                                                                                    ---                  ------                 -----

    Total net revenues                                                                                                                                                                          106,731                 203,914                32,833

    Cost of revenues

    Network                                                                                                                                                                                     (44,446)                (49,844)               (8,025)

    Hospital-Medicine cost                                                                                                                                                                            -                 (33,893)               (5,457)

    Hospital-Medical service cost                                                                                                                                                                     -                 (48,704)               (7,842)
                                                                                                                                                                                                    ---                 -------                ------

    Total cost of revenues                                                                                                                                                                      (44,446)               (132,441)              (21,324)

    Gross profit                                                                                                                                                                                 62,285                  71,473                11,509

    Operating expenses

    Selling expenses                                                                                                                                                                             (7,979)                (16,457)               (2,650)

    General and administrative expenses                                                                                                                                                         (16,965)                (25,403)               (4,090)
                                                                                                                                                                                                -------                 -------                ------

    Operating income                                                                                                                                                                             37,341                  29,613                 4,769

    Interest expenses                                                                                                                                                                            (3,810)                 (9,276)               (1,494)

    Foreign exchange gain,net                                                                                                                                                                        60                       2                     -

    Loss on disposal of property, plant and equipment                                                                                                                                            (1,396)                   (110)                  (18)

    Interest income                                                                                                                                                                               1,559                   5,443                   876

    Share of net profit of equity investees                                                                                                                                                           -                   4,238                   682

    Other (expense) income, net                                                                                                                                                                       7                     (58)                   (9)
                                                                                                                                                                                                    ---                     ---                   ---

    Income before income taxes                                                                                                                                                                   33,761                  29,852                 4,806

    Income tax expenses                                                                                                                                                                          (8,773)                (10,812)               (1,741)

    Net income                                                                                                                                                                                   24,988                  19,040                 3,065
                                                                                                                                                                                                 ======                  ======                 =====

    Net (loss) income attributable to noncontrolling interests                                                                                                                                      809                    (643)                 (104)

    Net income attributable to ordinary shareholders                                                                                                                                             24,179                  19,683                 3,169
                                                                                                                                                                                                 ======                  ======                 =====

    Earnings per ADS

    Basic /Diluted                                                                                                                                                                                 0.52                    0.44                  0.07

    Weighted average number of ADS outstanding:

    Basic /Diluted                                                                                                                                                                           46,849,399              45,098,232            45,098,232

    Other comprehensive  income, net of tax

    Foreign currency translation                                                                                                                                                                     28                     125                    20

    Total other comprehensive income, net of tax                                                                                                                                                     28                     125                    20
                                                                                                                                                                                                    ---                     ---                   ---

    Comprehensive income                                                                                                                                                                         25,016                  19,165                 3,085
                                                                                                                                                                                                 ------                  ------                 -----

    Comprehensive income (loss) attributable to noncontrolling interests                                                                                                                            809                    (643)                 (104)
                                                                                                                                                                                                    ---                    ----                  ----

    Comprehensive income attributable to Concord Medical Services                                                                                                                                24,207                  19,808                 3,189
    Holdings Limited's shareholders

    (*) Certain amounts in the prior year quarterly financial information are being reclassified for comparison purposes.

    Reconciliations of non-GAAP results of operations measures to the nearest comparable GAAP measures (*) (in RMB thousands, unaudited)

                                                                     For the three months ended March 31, 2012                                 For the three months ended March 31, 2013
                                                                     -----------------------------------------                                 -----------------------------------------

                                                                                    GAAP Measure                            Adjustment                      Non-GAAP Measure                  GAAP Measure        Adjustment       Non-GAAP Measure
                                                                                    ------------                            ----------                      ----------------                  ------------        ----------       ----------------

    Operating income                                                                                    37,341                           2,271                                         39,612              29,613            2,244                  31,857

    Net income                                                                                          24,988                           2,271                                         27,259              19,040            2,244                  21,284

    Basic earnings per ADS                                                                                0.52                            0.05                                           0.57                0.44             0.05                    0.49

    Diluted earnings per ADS                                                                              0.52                            0.05                                           0.57                0.44             0.05                    0.49

    (*) The only adjustment is share-based compensation.

    Reconciliation from net income to adjusted EBITDA(*) (in RMB thousands, unaudited)

                                                                                    For the three months ended                                   For the three months ended
                                                                                    --------------------------                                   --------------------------

                                                                                          March 31, 2012                                               March 31, 2013
                                                                                          --------------                                               --------------

    Net income                                                                                                                24,988                                        19,040

    Interest expenses, net                                                                                                     2,251                                         9,276

    Income tax expenses                                                                                                        8,773                                        10,812

    Depreciation and amortization                                                                                             33,964                                        47,473

    Share-based compensation                                                                                                   2,271                                         2,244

    Other adjustments                                                                                                          1,329                                           166

    Adjusted EBITDA                                                                                                           73,576                                        89,011
                                                                                                                              ======                                        ======

    (*) Definition of adjusted EBITDA: Adjusted EBITDA is defined as net income plus interest, taxes, depreciation and amortization, share-based
    compensation expenses and other adjustments. Other adjustments include foreign exchange gain, loss from disposal of property, plant and
    equipment and other income or expense.

————————————————————————————————————–

    [1] This announcement contains
     translations of certain RMB amounts
     into U.S. dollars at specified
     rates solely for the convenience of
     the reader. Unless otherwise noted,
     all translations from RMB to U.S.
     dollars are made at a rate of
     RMB6.2108 to US$1.00, the effective
     noon buying rate as of March 31,
     2013 in the City of New York for
     cable transfers of RMB as certified
     for customs purposes by the Federal
     Reserve Bank of New York.

    [2] Each ADS represents three
     ordinary shares of the Company.

    [3] Definition of adjusted EBITDA:
     Adjusted EBITDA is defined as net
     income plus interest, taxes,
     depreciation and amortization,
     share-based compensation expenses
     and other adjustments. Other
     adjustments include foreign
     exchange gain, loss from disposal
     of property, plant and equipment
     and other income or expense.

SOURCE Concord Medical Services Holdings Limited


Source: PR Newswire